04.17.21
CureVac’s COVID-19 Vaccine Attracts Rising Interest
FRANKFURT (Reuters) – German biotech firm CureVac said it has seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, as concerns over rare side effects have hit some other coronavirus shots. A CureVac spokesman said on Thursday that requests have been coming in from various quarters, including governments